Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

State medical board regulation of compounding in physician offices.

Reynolds KA, Hellquist K, Ibrahim SA, et al. State medical board regulation of compounding in physician offices. Arch Dermatol Res. 2022;314(4):363-367. doi:10.1007/s00403-021-02237-8.

Save
Print
June 9, 2021
Reynolds KA, Hellquist K, Ibrahim SA, et al. Arch Dermatol Res. 2022;314(4):363-367.
View more articles from the same authors.

Adverse events associated with pharmacy compounding (e.g., parenteral nutrition, sterile compounding) are well-documented. This survey of state medical and osteopathic boards gathered information about compounding-associated adverse events in physician offices and use of compounding standards. Findings indicate that the incidence of in-office compounding-related adverse events is low and that the majority of respondents had not incorporated compounding standards into their regulations.

Save
Print
Cite
Citation

Reynolds KA, Hellquist K, Ibrahim SA, et al. State medical board regulation of compounding in physician offices. Arch Dermatol Res. 2022;314(4):363-367. doi:10.1007/s00403-021-02237-8.